Milestone Scientific (MLSS) 1.9500 $MLSS
Milestone Scientific Announces Planned Merger of Its JV, Milestone Ophthalmic Sp. z o.o., With EWH and Listing of Common Stock on the Warsaw Stock Exchange
Marketwire - Mon Sep 22, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its recently formed Joint Venture, Milestone Ophthalmic Sp. z o.o., plans to merge with Emmerson Wierzytelnosci Hipoteczne S.A. ("EWH"
to effect a listing of its common stock on the New Connect market of the Warsaw Stock Exchange, subject to certain final terms and conditions of the merger agreement.
Milestone Scientific Receives CE Mark Approval for Epidural Injection System
Marketwire - Thu Sep 18, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidiary, Milestone Medical, has received CE Mark to market and sell its epidural injection system in Europe. The CompuFlo(TM) Epidural Computer Controlled Anesthesia System (CompuFlo(TM) Epidural Model 6000) is intended for the verification of needle tip placement in the lumbar epidural space in patients over age of 18 and the delivery of medication and other fluids in a controlled manner in the lumbar epidural space as part of an in-patient or out-patient procedure established by their Health Care Provider.
Milestone Scientific and Milestone China Form New Dermatological Joint Venture
Marketwire - Tue Sep 16, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced it has formed a dermatological joint venture with Milestone China. The new joint venture entity, Milestone Advanced Cosmetic Systems, Inc., will be 50% owned by Milestone Scientific and 50% owned by Milestone China. Milestone China will contribute $900,000 and Milestone Scientific will contribute a limited license to use its technology to the joint venture for the development of a botox injection system, consisting of a computer controlled injection device and a related disposable. As previously announced, Milestone China is a joint venture distribution company between Milestone Scientific and a team headed by a senior healthcare executive from China. The focus of Milestone China is to supply and distribute medical and dental instruments, and disposables to China and other Asian markets.
Milestone Scientific passes CE Mark approval for intra-articular instrument
M2 - Mon Sep 15, 7:01AM CDT
Medical company Milestone Scientific (Other OTC:MLSS) disclosed on Monday that its subsidiary, Milestone Medical, has secured CE Mark regulatory approval to market and sell its intra-articular instrument in Europe.
Milestone Scientific Receives CE Mark Approval for Intra-Articular Instrument
Marketwire - Mon Sep 15, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidiary, Milestone Medical, has received CE Mark regulatory approval to market and sell its intra-articular instrument in Europe.
Milestone Scientific to Present at the Aegis Capital Healthcare & Technology Conference in Las Vegas
Marketwire - Mon Sep 08, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Thursday, September 11th at 3:00 p.m. Pacific Time at the 2014 Aegis Capital Healthcare & Technology Conference at The Encore at Wynn in Las Vegas.
Milestone Scientific Announces Financial Results for the Second Quarter of 2014
Marketwire - Thu Aug 14, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results and provided a business update for the three and six months ended June 30, 2014.
Milestone Scientific Schedules Second Quarter 2014 Earnings Conference Call
Marketwire - Mon Aug 11, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:30 a.m. Eastern Time on Thursday, August 14, 2014 to discuss the Company's financial results for the second quarter ended June 30, 2014, as well as the Company's corporate progress and other developments.
Milestone Scientific, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
Marketwire - Thu Jul 31, 11:18AM CDT
Milestone Scientific Inc. (OTCQB: MLLS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it has retained Maxim Group LLC, a leading premier investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services. Maxim will focus on assisting Milestone in its strategies for maximizing shareholder value through its full scope of investment banking services.
Milestone Scientific Appoints Senior Healthcare Industry Executive Steven F. Robins as Marketing Consultant
Marketwire - Wed Jul 30, 6:32AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins to the position of Marketing Consultant.
Merriman Capital Initiates on Milestone Scientific, Inc. with a Buy Rating
Thomson Reuters ONE - Thu Jul 17, 8:45AM CDT
SAN FRANCISCO - July 17, 2014 - Merriman Capital, Inc. ("Merriman" , a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced that it has initiated equity research coverage of Milestone Scientific, Inc. (OTCQB: MLSS) with a Buy rating and a $3.00 price target.
International Sales Continue to Boost Becton, Dickinson - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 5:15PM CDT
Becton, Dickinson (BDX) maintains its focus on geographical expansion into overseas markets, in particular, emerging markets
Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:39AM CDT
Antares Pharma has seen flat earnings estimate revisions for the current quarter along with a significant decline in its share price for the last day
First Taker for Becton, Dickinson's Cato Workflow Solution - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 12:10PM CDT
Becton, Dickinson and Company's (BDX) BD Cato Workflow Solution is an integrated software system that draws on barcode technology and gravimetric verification to enhance patient safety and optimize workflow efficiency in medication preparation.
CR Bard Expands Share Repurchase Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 12:40PM CDT
In addition, CR Bard (BCR) raised the quarterly dividend on its stock by 5% to 22 cents per share.
CR Bard's Lutonix DCB Moves Closer to FDA Clearance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 2:40PM CDT
If sanctioned, CR Bard Inc.'s (BCR) Lutonix DCB is expected to be the first and only FDA-approved DCB in the U.S.
Becton, Dickinson Unveils Blood Culture Instrument Connectivity - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 12:15PM CDT
Becton, Dickinson and Company (BDX) will now provide connectivity of the fully automated microbiology growth and detection technology BD BACTEC Blood Culture System with BD EpiCenter Microbiology Data Management System
Milestone Scientific Reports Fourth Quarter and 2013 Financial Results
Marketwire - Wed Mar 12, 6:08PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the fourth quarter and year ended December 31, 2013.
Milestone Scientific Anticipates Significant Increase in Wand(R) Handpiece Sales in Second Half of 2014
Marketwire - Mon Mar 10, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Aseptico, its exclusive dental distributor, will now only sell Milestone's STA Wand® handpieces directly to dentists and will no longer sell through third-party distributors. As a result, the Company announced that it anticipates increased Wand® handpiece sales in the second half of 2014 due to the greater transparency and direct contact it will have with dentists through Aseptico.
Milestone Scientific Schedules 2013 Year-End Earnings Conference Call
Marketwire - Fri Mar 07, 10:10AM CST
Milestone Scientific, Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 8:30 a.m. Eastern Daylight Time on Thursday, March 13, 2014 to discuss the company's financial results for the fourth quarter and full year ending December 31, 2013, as well as the Company's corporate progress and other meaningful developments.
Milestone Scientific Announces Planned Merger of Its JV, Milestone Ophthalmic Sp. z o.o., With EWH and Listing of Common Stock on the Warsaw Stock Exchange
Marketwire - Mon Sep 22, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its recently formed Joint Venture, Milestone Ophthalmic Sp. z o.o., plans to merge with Emmerson Wierzytelnosci Hipoteczne S.A. ("EWH"
to effect a listing of its common stock on the New Connect market of the Warsaw Stock Exchange, subject to certain final terms and conditions of the merger agreement. Milestone Scientific Receives CE Mark Approval for Epidural Injection System
Marketwire - Thu Sep 18, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidiary, Milestone Medical, has received CE Mark to market and sell its epidural injection system in Europe. The CompuFlo(TM) Epidural Computer Controlled Anesthesia System (CompuFlo(TM) Epidural Model 6000) is intended for the verification of needle tip placement in the lumbar epidural space in patients over age of 18 and the delivery of medication and other fluids in a controlled manner in the lumbar epidural space as part of an in-patient or out-patient procedure established by their Health Care Provider.
Milestone Scientific and Milestone China Form New Dermatological Joint Venture
Marketwire - Tue Sep 16, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced it has formed a dermatological joint venture with Milestone China. The new joint venture entity, Milestone Advanced Cosmetic Systems, Inc., will be 50% owned by Milestone Scientific and 50% owned by Milestone China. Milestone China will contribute $900,000 and Milestone Scientific will contribute a limited license to use its technology to the joint venture for the development of a botox injection system, consisting of a computer controlled injection device and a related disposable. As previously announced, Milestone China is a joint venture distribution company between Milestone Scientific and a team headed by a senior healthcare executive from China. The focus of Milestone China is to supply and distribute medical and dental instruments, and disposables to China and other Asian markets.
Milestone Scientific passes CE Mark approval for intra-articular instrument
M2 - Mon Sep 15, 7:01AM CDT
Medical company Milestone Scientific (Other OTC:MLSS) disclosed on Monday that its subsidiary, Milestone Medical, has secured CE Mark regulatory approval to market and sell its intra-articular instrument in Europe.
Milestone Scientific Receives CE Mark Approval for Intra-Articular Instrument
Marketwire - Mon Sep 15, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidiary, Milestone Medical, has received CE Mark regulatory approval to market and sell its intra-articular instrument in Europe.
Milestone Scientific to Present at the Aegis Capital Healthcare & Technology Conference in Las Vegas
Marketwire - Mon Sep 08, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Thursday, September 11th at 3:00 p.m. Pacific Time at the 2014 Aegis Capital Healthcare & Technology Conference at The Encore at Wynn in Las Vegas.
Milestone Scientific Announces Financial Results for the Second Quarter of 2014
Marketwire - Thu Aug 14, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results and provided a business update for the three and six months ended June 30, 2014.
Milestone Scientific Schedules Second Quarter 2014 Earnings Conference Call
Marketwire - Mon Aug 11, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:30 a.m. Eastern Time on Thursday, August 14, 2014 to discuss the Company's financial results for the second quarter ended June 30, 2014, as well as the Company's corporate progress and other developments.
Milestone Scientific, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
Marketwire - Thu Jul 31, 11:18AM CDT
Milestone Scientific Inc. (OTCQB: MLLS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it has retained Maxim Group LLC, a leading premier investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services. Maxim will focus on assisting Milestone in its strategies for maximizing shareholder value through its full scope of investment banking services.
Milestone Scientific Appoints Senior Healthcare Industry Executive Steven F. Robins as Marketing Consultant
Marketwire - Wed Jul 30, 6:32AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins to the position of Marketing Consultant.
Merriman Capital Initiates on Milestone Scientific, Inc. with a Buy Rating
Thomson Reuters ONE - Thu Jul 17, 8:45AM CDT
SAN FRANCISCO - July 17, 2014 - Merriman Capital, Inc. ("Merriman"
, a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced that it has initiated equity research coverage of Milestone Scientific, Inc. (OTCQB: MLSS) with a Buy rating and a $3.00 price target. International Sales Continue to Boost Becton, Dickinson - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 5:15PM CDT
Becton, Dickinson (BDX) maintains its focus on geographical expansion into overseas markets, in particular, emerging markets
Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:39AM CDT
Antares Pharma has seen flat earnings estimate revisions for the current quarter along with a significant decline in its share price for the last day
First Taker for Becton, Dickinson's Cato Workflow Solution - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 12:10PM CDT
Becton, Dickinson and Company's (BDX) BD Cato Workflow Solution is an integrated software system that draws on barcode technology and gravimetric verification to enhance patient safety and optimize workflow efficiency in medication preparation.
CR Bard Expands Share Repurchase Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 12:40PM CDT
In addition, CR Bard (BCR) raised the quarterly dividend on its stock by 5% to 22 cents per share.
CR Bard's Lutonix DCB Moves Closer to FDA Clearance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 2:40PM CDT
If sanctioned, CR Bard Inc.'s (BCR) Lutonix DCB is expected to be the first and only FDA-approved DCB in the U.S.
Becton, Dickinson Unveils Blood Culture Instrument Connectivity - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 12:15PM CDT
Becton, Dickinson and Company (BDX) will now provide connectivity of the fully automated microbiology growth and detection technology BD BACTEC Blood Culture System with BD EpiCenter Microbiology Data Management System
Milestone Scientific Reports Fourth Quarter and 2013 Financial Results
Marketwire - Wed Mar 12, 6:08PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the fourth quarter and year ended December 31, 2013.
Milestone Scientific Anticipates Significant Increase in Wand(R) Handpiece Sales in Second Half of 2014
Marketwire - Mon Mar 10, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Aseptico, its exclusive dental distributor, will now only sell Milestone's STA Wand® handpieces directly to dentists and will no longer sell through third-party distributors. As a result, the Company announced that it anticipates increased Wand® handpiece sales in the second half of 2014 due to the greater transparency and direct contact it will have with dentists through Aseptico.
Milestone Scientific Schedules 2013 Year-End Earnings Conference Call
Marketwire - Fri Mar 07, 10:10AM CST
Milestone Scientific, Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that it will host a conference call at 8:30 a.m. Eastern Daylight Time on Thursday, March 13, 2014 to discuss the company's financial results for the fourth quarter and full year ending December 31, 2013, as well as the Company's corporate progress and other meaningful developments.
